WEDNESDAY, MARCH 18

11:00am – 3:30pm: INSTITUTES
1:00 – 4:00pm: HIV PCP INSTITUTE
1:00 – 5:00pm: HIV PNC INSTITUTE
4:00 – 5:30pm: TRACK SESSIONS

THURSDAY, MARCH 19

9:00 – 10:30am: PLENARY SESSION
10:45am – 12:15pm: TRACK SESSIONS
12:30 – 2:00pm: LUNCH PLENARY
2:15 – 3:45pm: TRACK SESSIONS
4:00 – 5:30pm: TRACK SESSIONS

FRIDAY, MARCH 20

9:00 – 10:30am: PLENARY SESSION
10:45am – 12:15pm: TRACK SESSIONS
12:30 – 2:00pm: LUNCH PLENARY

This schedule is preliminary and subject to change.

  • Critical Thinking and Cultural Affirmation (CTCA) Intervention

    Studio B
    Health Equity Track

    This session explores how CTCA blends peer-led support, expressive arts, cultural rituals, and critical consciousness to foster emotional wellness, increase HIV care retention, and support prevention. Participants will engage with evidence-based strategies and real-world examples demonstrating CTCA’s success in improving health outcomes while affirming identity and restoring community connection.

  • I’m Not a Monster: Examining Media Bias and Stigma in Florida News Coverage of HIV-related Arrests

    Studio B
    Health Equity Track

    This study examines media bias and stigma in Florida news coverage of HIV-related arrests from 2010 to 2020. A systematic content analysis of 129 news articles revealed disproportionate racial and gender portrayals, with Black men overrepresented as perpetrators despite data showing White women constitute the majority of those arrested. Findings indicate widespread use of stigmatizing language and sensationalized reporting, which amplify public misconceptions about HIV transmission and criminalization.

  • Findings From a Formative Evaluation of Hepatitis C Virus (HCV) Care and Treatment Co-Located in Non-Traditional Service Settings for People Who Use Drugs in New York State

    Boardroom
    Hepatitis C Track

    Understanding that the complexity and segmentation of the healthcare system can pose unique challenges to providing medical care in non-traditional settings in the United States, a formative evaluation was conducted to assess the feasibility, acceptability, and effectiveness, and whether enrolled clients completed the care cascade measured by four performance indicators: linkage to care, treatment initiation, treatment completion, and achievement of SVR-12.

  • Iowa ReLink: Lessons Learned and Informing Future Directions for Ending HCV with a Syndemic Response

    Boardroom
    Hepatitis C Track

    This session will review the project design and provide an overview of preliminary project outcomes, specifically focusing on the unique role State Health Agencies are equipped to fulfill when seeking to generate registries, verify eligibility, and engage individuals. Finally, the session will discuss how these activities have informed the development of a syndemic framework aimed at ending HCV with strategies focused on disrupting transmission in real time while also addressing HIV and STIs.

  • No Missed Opportunities: A Client-Centered Telehealth Model for Hepatitis C in Inpatient Substance Use Treatment Programs

    Boardroom
    Hepatitis C Track

    People who use drugs (PWUDs) face structural barriers to access prevention and care for hepatitis C (HCV) infection. While many inpatient substance use treatment programs (ISUTPs) often screen for HCV, few provide treatment, leading to missed opportunities for care. This presentation will introduce a client-centered telehealth model, initiating HCV treatment during detoxification and rehabilitation to enhance early engagement and ensure continuity of care.

  • An Indictment of US Public Health Policy on Pain and Addiction Management

    Studio C
    Drug User Health Track

    This presentation addresses the intersection of issues in health equity and justice, versus health advocacy and policy, to identify and contradict the significant misdirection and fatal errors of science in recent opioid prescribing guidelines of the US CDC and Veterans Administration with a critical review of published clinical and demographic data on safety and effectiveness of prescription opioid analgesic pain relievers.

  • Diverse, Low Barrier MAT Programs: Case Studies for Increasing Access to Prevent Overdose

    Potomac B
    Drug User Health Track

    This presentation will explore the process and findings of this landscape analysis, sharing some key case study videos and highlighting the various creative ways that programs have integrated MAT treatment into existing models even if they do not have a prescribing provider onsite. Participants will become familiarized with the meaning and significance of low barriers services in an MAT setting, and will discuss various ways that MAT programs have been successful in preventing overdose and improving the overall health and wellness of their clients through provision of MAT.

  • Participant Centered Recommendations for Contingency Management Program Implementation

    Studio C
    Drug User Health Track

    Contingency Management (CM) is a behavioral intervention option for stimulant use that involves immediate, tangible rewards to individuals to reinforce positive self-identified behavior change. In 2023, in response to rising rates of stimulant overdose deaths, California became the first state in the U.S. to offer CM as a benefit through public insurance. Having already embraced CM over two decades prior through the Positive Reinforcement Opportunity Project (PROP)—originally designed for men who have sex with men to reduce sexually transmitted infections through reducing methamphetamine use—San Francisco was well positioned to expand this model, and over the last two years expanded CM to more than a dozen programs throughout the city benefitting diverse populations.

  • Harm Reduction: Getting It Right

    Studio C
    Drug User Health Track

    This conversation centers harm reduction not as a checklist, but as a justice-rooted framework, a commitment to dignity, autonomy, and survival in a world that often withholds those things. We’ll explore how harm is exacerbated by systems of criminalization, medical neglect, stigma, and control, especially for people who use drugs, sell sex, live with chronic illness, or navigate poverty, racism, and ableism. We’ll interrogate how harm reduction gets watered down, co-opted, or professionalized into meaninglessness, and what it means to reclaim it as a radical, liberatory practice.

  • Inaugural Year Highlights from the Harm Reduction Services Program: San Diego County’s First Government-Run Syringe Service Program

    Potomac B
    Drug User Health Track

    In April 2024, San Diego County launched its Harm Reduction Services Program (HRSP), the region’s first government-run syringe service initiative. Designed to address the intersecting crises of overdose, HIV, and hepatitis C among people who use drugs, HRSP operates through a mobile delivery model, providing low-barrier, stigma-free services in underserved communities identified through a comprehensive Community Readiness Assessment.

  • Cool Kids Carry Narcan: A Rural Community Model for Equitable Naloxone Access and Overdose Prevention

    Potomac B
    Drug User Health Track

    Cool Kids Carry Narcan is a rural overdose prevention initiative led by Berkshire Harm Reduction, a program of Berkshire Health Systems in western Massachusetts. Designed to address geographic and racial inequities in naloxone access, the project currently installs and maintains 124 public NaloxBoxes while pairing distribution with community training and stigma-reduction campaigns.

  • Hep C Crash Course: Managing Hepatitis C Treatment in Primary Care Settings

    Boardroom
    Hepatitis C Track

    This session provides a five-step roadmap for integrating HCV care into primary care practice. Attendees will learn how to conduct reflex-based screening, stage fibrosis using labs or portable tools, select treatment regimens aligned with AASLD-IDSA guidelines, navigate medication access barriers, and monitor patients through to sustained virologic response (SVR).

  • From Policy to Practice: Defending and Advancing LGBTQ+ Health in California

    Potomac A

    This special session will: Identify key challenges and political pressures affecting LGBTQ+ health services in California, and examine how healthcare leaders are navigating institutional and regulatory constraints; Analyze real-world strategies and best practices used by health systems and community organizations to protect, sustain, and advance LGBTQ+ affirming care across clinical, educational, and operational settings; and Apply lessons learned from diverse institutional contexts to strengthen participants’ own approaches to advocacy, policy implementation, and adaptive leadership in support of LGBTQ+ health.

  • Bodies in Sync: Upstream Prevention and Community Healing to Address the Policing and Stigma of Adolescent Bodies in BIPOC Communities

    Potomac B
    Drug User Health Track

    Bodies in Sync positions upstream prevention as a vehicle for healing and liberation. By synchronizing science, community, and culture, the session demonstrates that prevention is not solely about risk reduction—it is about creating conditions for youth to thrive, belong, and lead the next generation of public health innovation.

  • Too Big To Fail: What’s Next for the Federal Drug Pricing Program?

    Studio B

    This session features the ADAP Advocacy Association's 340B Patient Advisory Committee convening its first meeting of the year, featuring Dr. Rory Martin of IQVIA sharing his perspectives on the 340B Drug Pricing Program. The 340B Program has increasingly been targeted for reform by lawmakers at the federal and state levels, and by the Trump Administration's push to move the program to a rebate payment model. The 340B Patient Advisory Committee will convene its next meeting during SYNC to discuss ongoing executive orders, administrative rules, legislation, and pending litigation in numerous federal district courts and appellate courts.

  • Intercourse: Sex Ed for Congress

    Studio F
    HIV Prevention Track

    Power of PreventionThis presentation provides an update on federal reproductive healthcare and access litigation and policy, and highlights strategies for systems change, including policy reforms, advocacy, research, collaboration, and capacity-building to address the implications of unequal access to sex education.

  • Lived Experiences of Black Men Who Have Sex with Men in Washington, DC: Survival and Seroadaptation

    Potomac B
    HIV Care and Treatment Track

    Understanding how BMSM, who represent less than 1% of the U.S. population, but account for over one-third of new HIV infections annually, practice seroadaptation can inform new interventions to improve their engagement in HIV services. To this end, we conducted a qualitative study (called the “PhotoUStudy”), which was guided by a conceptual model, the BMSM Intersectional Identity Framework Over the Life Course (BMSM Identity Framework). Thirty-six BMSM who lived in/accessed health services in Washington, D.C., aged 18-65, were recruited into a five-day photovoice activity and follow-up interview.

  • Making the Uncomfortable Routine: Transforming Sexual Health Conversations in Rural Settings

    Studio F
    HIV Prevention Track

    Power of PreventionParticipants will learn “how-to” techniques for initiating and guiding conversations about sexual history through a lens of prevention, risk reduction, and patient-centered care. The presentation will emphasize creating a safe, respectful, and non-judgmental environment that encourages patients to ask questions and engage openly. Special attention will be given to the unique challenges faced in rural communities, where stigma, limited resources, and lack of formal education can further inhibit discussions about sexual health.

  • A Simulation Exercise to Improve Sexual Health and Wellness Training for Nurse Practitioner Students

    Studio E
    HIV Prevention Track

    Power of PreventionEvidence shows there are gaps in clinicians’ skills in providing comprehensive sexual health care across diverse populations. Simulation in clinical training has emerged as an effective pedagogy to facilitate student learning of knowledge, skills, and attitudes on a variety of healthcare topics. Faculty at the University of Rochester School of Nursing developed a sexual health simulation for three graduate nurse practitioner (NP) programs (Adult-Gerontology, Family, and Pediatric Primary Care).

  • Blueprint for Expanding HIV Testing in Your Community

    Studio E
    HIV Prevention Track

    Power of PreventionThis presentation will highlight how to build a successful HIV testing program in the community. These are not abstract methods, but concrete steps to provide a clear plan on creating an HIV testing program that will ensure more people will have access to free, rapid testing.

  • Developing Linkage to Comprehensive Prevention Services in an Emergency Department Setting

    Studio E
    HIV Prevention Track

    Power of PreventionThis presentation will discuss the opportunities for implementing linkage to comprehensive services by assessing populations who are seen in the ED testing for STIs, including syphilis and HIV. We will explore the operations of identifying eligible patients, including our collaborations with the public health department, our Infectious Disease Clinic, and our Title V Clinic. We will highlight what is going well and discuss areas of improvement.
    This presentation will also review the successes and challenges of launching a rapid PrEP program in an ED setting.

Accreditation, Credit, and Support

Information on credits offered to SYNC participants for attending institutes, sessions, and plenaries — live or in-person — is available here.

Commercial Support Acknowledgement

This conference is supported, in part, by independent educational grants from ineligible companies. A full list of supporters is available here. All accredited content has been developed and delivered in accordance with the ACCME Standards for Integrity and Independence and the criteria of Joint Accreditation for Interprofessional Continuing Education™, and is free of commercial bias.